Therapeutic Goods Administration (Australia)
GPTKB entity
Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:government_agency
|
| gptkbp:abbreviation |
gptkb:TGA
|
| gptkbp:country |
gptkb:Australia
|
| gptkbp:established |
1989
|
| gptkbp:headquarters_location |
gptkb:Canberra
|
| https://www.w3.org/2000/01/rdf-schema#label |
Therapeutic Goods Administration (Australia)
|
| gptkbp:jurisdiction |
gptkb:Australia
|
| gptkbp:parentOrganization |
gptkb:Australian_Government_Department_of_Health_and_Aged_Care
|
| gptkbp:regulates |
adverse event reporting
medical devices vaccines product quality packaging over-the-counter medicines prescription medicines product recalls diagnostic tests product safety product registration disinfectants product labelling post-market surveillance biologicals complementary medicines product listing product standards blood and blood products cell and tissue products clinical trials of therapeutic goods cosmetic injectables export and import of therapeutic goods gene technology products manufacturing standards for therapeutic goods product advertising product efficacy product inclusion product supply product withdrawals recalls of therapeutic goods safety monitoring of therapeutic goods sunscreens therapeutic goods advertising |
| gptkbp:responsible_for |
regulation of medical devices
regulation of vaccines regulation of blood products regulation of medicines regulation of gene technology regulation of therapeutic goods |
| gptkbp:website |
https://www.tga.gov.au/
|
| gptkbp:bfsParent |
gptkb:ICH
gptkb:COVID-19_vaccine_development_(Moderna) gptkb:CSL_Limited |
| gptkbp:bfsLayer |
6
|